Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Urology · Benign Prostatic Hyperplasia

Will My Prostate Keep Growing? BPH Retention and Surgery Risk

At a Glance

BPH often grows with age, but prostate size, symptoms, and blockage do not always worsen together. Larger prostates, severe symptoms, more urine left in the bladder, and prostate tissue bulging into the bladder raise the risk of urinary retention or surgery; some medicines can lower that risk.

While a prostatic adenoma (benign prostatic hyperplasia or BPH—a non-cancerous enlargement of the prostate) typically grows as you age, severe symptoms, needing a catheter, or requiring surgery are not inevitable [1][2]. Prostate growth varies widely from person to person. For many men, the prostate enlarges but never causes enough obstruction to require major medical intervention [2]. However, for others, the growing prostate can gradually block the flow of urine, which may eventually lead to acute urinary retention (a sudden inability to urinate) or the need for a surgical procedure [3].

Understanding the Natural History of BPH

The “natural history” of a condition refers to how it progresses over time without treatment. Microscopic evidence of BPH is incredibly common, found in about 80% of men in their 70s [4]. However, having microscopic cellular growth does not guarantee trouble. Histologic BPH does not inevitably cause the prostate to noticeably enlarge, and even an enlarged prostate does not necessarily cause bladder outlet obstruction (a physical blockage of urine) or bothersome lower urinary tract symptoms (LUTS) [2].

Prostate size, urinary symptoms, and obstruction do not always progress together. Symptoms can remain stable for years, fluctuate, or worsen [1]. Therefore, your future trajectory cannot be predicted by your age alone.

Risk Factors: Who is Most Likely to Progress?

Because progression is variable, clinicians look at several “puzzle pieces” to estimate if your BPH is likely to worsen and eventually require surgery or a catheter. No single measurement dictates your future; they are evaluated together:

  • Larger prostate volume: Bigger prostates are generally more likely to cause future obstruction and require treatment [3][5].
  • Higher PSA levels: Prostate-Specific Antigen (PSA) is a blood test. In men without prostate cancer, a higher PSA often correlates with a larger, faster-growing prostate and a higher risk of needing surgery [3]. Note: PSA can also rise due to prostate cancer, urinary infections, or inflammation. An unexplained high PSA always requires clinical evaluation and should not be assumed to be just BPH.
  • Severe baseline symptoms: Men who already experience a high symptom burden (often measured by a questionnaire called the IPSS) have a higher hazard of their condition worsening [3].
  • Low peak urinary flow: A weaker urine stream during a flow test suggests a higher risk of future complications [3]. However, a weak stream can also be caused by an underactive bladder muscle, not just a physical blockage.
  • High post-void residual (PVR): PVR is the amount of urine left in your bladder after you pee, usually measured by a quick ultrasound. A higher residual volume is associated with a greater likelihood of needing surgery [5]. There is no single universal “cutoff” number that mandates surgery.
  • Intravesical prostatic protrusion (IPP): This occurs when a portion of the prostate (the middle lobe) grows upward into the bladder, acting like a ball valve. When seen on imaging, severe IPP is strongly associated with an increased risk of sudden urinary retention or needing surgery [6][7].
  • Older age: Advancing age independently increases the risk of emergency hospital visits for urinary retention [8].

Complications: Retention and Surgery

When an enlarged prostate causes severe obstruction, the bladder must work harder to push urine out. If this progresses unmanaged, it can lead to complications.

When to Seek Urgent Care

The most immediate risk of progressive BPH is acute urinary retention (AUR)—a sudden inability to pass urine. While often accompanied by painful lower-abdominal fullness, it is not always painful [3].

If you are suddenly unable to urinate—especially if you have severe lower-abdominal pain, lower-abdominal fullness, fever, chills, or visible blood with clots—you require immediate, same-day emergency assessment [8]. Do not wait for a routine appointment. A doctor will typically need to drain the bladder with a catheter.

Chronic Risks and Surgical Timing

If the bladder consistently fails to empty properly (chronic retention), stagnant urine can occasionally lead to recurrent urinary tract infections (UTIs), bladder stones, or impaired kidney function, though these are not inevitable for everyone with BPH [5][9].

When urinary retention requires a catheter, deciding if and when to have surgery is highly individualized. However, observational data suggests that relying on repeated emergency catheterizations or significantly delaying surgery after recurrent retention episodes can increase the risk of the eventual surgery failing to permanently fix the problem [10].

Changing Your Trajectory

Your natural history is not set in stone. Routine monitoring (like symptom diaries, selective flow tests, or residual urine checks) allows you and your doctor to identify changes before an emergency strikes [11].

Medical treatments can also significantly alter the progression of BPH:

  • Alpha-blockers (e.g., tamsulosin): These relax the muscles of the prostate and bladder neck to improve urine flow. While they help with symptoms, they do not shrink the prostate or stop its long-term growth [3]. Side effects can include dizziness, low blood pressure, and changes in ejaculation [12].
  • 5-alpha-reductase inhibitors (5-ARIs) (e.g., dutasteride, finasteride): These medications can actually shrink the prostate over several months. In clinical trials, they reduced the relative risk of experiencing acute urinary retention or needing BPH-related surgery by over 50% compared to a placebo over a multi-year period [3]. For high-risk men, delaying this type of therapy can substantially increase the absolute risk of needing surgery later [13].
    • Important Context: 5-ARIs can take up to 6 months to work. Side effects may include reduced libido, erectile dysfunction, and breast tenderness. They also artificially lower your PSA levels by about half, which your doctor must account for when screening for prostate cancer [14].

For men with mild or non-bothersome symptoms, conservative management—such as reducing evening fluids, minimizing caffeine and alcohol, and avoiding certain decongestant medications—can be appropriate [15]. Ultimately, treatment decisions should be a shared choice between you and your clinician based on your specific anatomy, symptom bother, and personal values [11].

Common questions in this guide

Does BPH always get worse as I get older?
No. Benign prostatic hyperplasia and prostate enlargement become more common with age, but prostate size, urinary symptoms, and blockage do not always worsen together. Some men remain stable for years and never need a catheter or surgery.
What makes urinary retention or BPH surgery more likely?
Risk is higher with a larger prostate, more severe urinary symptoms, a weak urine flow, more urine left in the bladder after urination, a portion of the prostate bulging into the bladder, and older age. A higher PSA may also signal higher risk after prostate cancer, infection, and inflammation have been evaluated. No single measurement predicts the future by itself.
What should I do if I suddenly cannot urinate?
Sudden inability to urinate is acute urinary retention and needs same-day emergency assessment, even if it is not very painful. Seek urgent care especially if you have lower-abdominal pain or fullness, fever, chills, or blood clots in the urine. A clinician will usually drain the bladder with a catheter.
Can BPH medicine prevent urinary retention or the need for surgery?
Alpha-blockers such as tamsulosin can improve urine flow and symptoms but do not shrink the prostate or stop its growth. Finasteride and dutasteride can shrink the prostate over several months and lower the risk of acute retention or BPH-related surgery, especially in men at higher risk. These medicines can have side effects and lower PSA, so a clinician should guide their use and interpret PSA results.
How can my doctor estimate whether my BPH will progress?
Your clinician may consider prostate size, PSA, symptom severity, urine flow, and the amount of urine left after urination, along with imaging findings such as a prostate bulge into the bladder. Tracking symptoms and repeating selected tests over time can show whether your risk is changing. Decisions about monitoring or treatment should reflect your symptoms and preferences as well as these measurements.
How do finasteride and dutasteride affect PSA testing?
Finasteride and dutasteride can lower PSA by about half, so a PSA result while taking them cannot be interpreted in the usual way. Tell the clinician who orders the test that you take a 5-alpha-reductase inhibitor, and ask how the result will be adjusted when screening for prostate cancer.

Get notified when new evidence is published on prostatic adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome.

    Stewart KL, Lephart ED

    International journal of molecular sciences 2023; (24(6)) doi:10.3390/ijms24065486.

    PMID: 36982560
  2. 2

    Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.

    DeLay KJ, McVary KT

    The Urologic clinics of North America 2016; (43(3)):371-5.

    PMID: 27476129
  3. 3

    Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms.

    D'Agate S, Chavan C, Manyak M, et al.

    British journal of clinical pharmacology 2021; (87(7)):2777-2789 doi:10.1111/bcp.14682.

    PMID: 33247951
  4. 4

    The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia.

    Taoka R, Kakehi Y

    Asian journal of urology 2017; (4(3)):158-163 doi:10.1016/j.ajur.2017.02.004.

    PMID: 29264225
  5. 5

    Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.

    Basnet S, Shrestha PM, Shrestha A, et al.

    Journal of Nepal Health Research Council 2023; (20(3)):768-773 doi:10.33314/jnhrc.v20i3.4613.

    PMID: 36974872
  6. 6

    Intravesical Prostatic Protrusion as a Predicting Factor for the Adverse Clinical Outcome in Patients With Symptomatic Benign Prostatic Enlargement Treated With Dutasteride.

    Yoshida T, Kinoshita H, Yoshida K, et al.

    Urology 2016; (91()):154-7.

    PMID: 26826590
  7. 7

    Clinical Outcomes of Intravesical Prostatic Protrusion in Patients With Benign Prostatic Hyperplasia.

    Al Rashed AA, Isa QM, Mahdi A, et al.

    Cureus 2024; (16(1)):e52541 doi:10.7759/cureus.52541.

    PMID: 38371165
  8. 8

    Disparities in Benign Prostatic Hyperplasia Progression: Predictors of Presentation to the Emergency Department in Urinary Retention.

    Patel PM, Sweigert SE, Nelson M, et al.

    The Journal of urology 2020; (204(2)):332-336 doi:10.1097/JU.0000000000000787.

    PMID: 31990248
  9. 9

    Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review.

    Babar M, Loloi J, Tang K, et al.

    Lower urinary tract symptoms 2022; (14(3)):140-154 doi:10.1111/luts.12435.

    PMID: 35233955
  10. 10

    Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference?

    Frendl DM, Chou WH, Chen YW, et al.

    The Journal of urology 2023; (210(3)):492-499 doi:10.1097/JU.0000000000003559.

    PMID: 37249443
  11. 11

    [Benign prostatic hyperplasia].

    Infante Hernández S, Gómez Rivas J, Moreno Sierra J

    Medicina clinica 2024; (163(8)):407-414 doi:10.1016/j.medcli.2024.04.014.

    PMID: 39013719
  12. 12

    [Medical treatment of patients with benign prostatic hyperplasia with 5-reductase inhibitors].

    Spivak LG, Platonova DV, Yagudaev DD

    Urologiia (Moscow, Russia : 1999) 2019; 175-179.

    PMID: 31535827
  13. 13

    Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression.

    D'Agate S, Chavan C, Manyak M, et al.

    World journal of urology 2021; (39(7)):2635-2643 doi:10.1007/s00345-020-03517-0.

    PMID: 33337513
  14. 14

    Best nonsurgical managements of acute urinary retention: what's new?

    Baboudjian M, Peyronnet B, Boissier R, et al.

    Current opinion in urology 2022; (32(2)):124-130 doi:10.1097/MOU.0000000000000969.

    PMID: 34954701
  15. 15

    Management and Treatment of Benign Prostatic Hyperplasia Symptoms: Current Insights.

    Zekraoui O, Bhojani N, Zorn KC, et al.

    Research and reports in urology 2025; (17()):401-420 doi:10.2147/RRU.S510367.

    PMID: 41054556

This page explains how BPH may progress and the risks of urinary retention or surgery for informational purposes only; it does not replace medical advice. Discuss your symptoms, prostate measurements, and treatment options with a qualified clinician.